Correlation Between Freeline Therapeutics and Immix Biopharma
Can any of the company-specific risk be diversified away by investing in both Freeline Therapeutics and Immix Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Freeline Therapeutics and Immix Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Freeline Therapeutics Holdings and Immix Biopharma, you can compare the effects of market volatilities on Freeline Therapeutics and Immix Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Freeline Therapeutics with a short position of Immix Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Freeline Therapeutics and Immix Biopharma.
Diversification Opportunities for Freeline Therapeutics and Immix Biopharma
0.75 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Freeline and Immix is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Freeline Therapeutics Holdings and Immix Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immix Biopharma and Freeline Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Freeline Therapeutics Holdings are associated (or correlated) with Immix Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immix Biopharma has no effect on the direction of Freeline Therapeutics i.e., Freeline Therapeutics and Immix Biopharma go up and down completely randomly.
Pair Corralation between Freeline Therapeutics and Immix Biopharma
Given the investment horizon of 90 days Freeline Therapeutics Holdings is expected to under-perform the Immix Biopharma. In addition to that, Freeline Therapeutics is 1.22 times more volatile than Immix Biopharma. It trades about -0.01 of its total potential returns per unit of risk. Immix Biopharma is currently generating about 0.02 per unit of volatility. If you would invest 234.00 in Immix Biopharma on August 28, 2024 and sell it today you would lose (62.00) from holding Immix Biopharma or give up 26.5% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 28.78% |
| Values | Daily Returns |
Freeline Therapeutics Holdings vs. Immix Biopharma
Performance |
| Timeline |
| Freeline Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Immix Biopharma |
Freeline Therapeutics and Immix Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Freeline Therapeutics and Immix Biopharma
The main advantage of trading using opposite Freeline Therapeutics and Immix Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Freeline Therapeutics position performs unexpectedly, Immix Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immix Biopharma will offset losses from the drop in Immix Biopharma's long position.| Freeline Therapeutics vs. Cns Pharmaceuticals | Freeline Therapeutics vs. ZyVersa Therapeutics | Freeline Therapeutics vs. Immix Biopharma | Freeline Therapeutics vs. Hepion Pharmaceuticals |
| Immix Biopharma vs. ZyVersa Therapeutics | Immix Biopharma vs. Hepion Pharmaceuticals | Immix Biopharma vs. Cns Pharmaceuticals | Immix Biopharma vs. Sonnet Biotherapeutics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |